1. Home
  2. RVNC vs MPLN Comparison

RVNC vs MPLN Comparison

Compare RVNC & MPLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVNC
  • MPLN
  • Stock Information
  • Founded
  • RVNC 1999
  • MPLN 1980
  • Country
  • RVNC United States
  • MPLN United States
  • Employees
  • RVNC N/A
  • MPLN N/A
  • Industry
  • RVNC Biotechnology: Pharmaceutical Preparations
  • MPLN Business Services
  • Sector
  • RVNC Health Care
  • MPLN Consumer Discretionary
  • Exchange
  • RVNC Nasdaq
  • MPLN Nasdaq
  • Market Cap
  • RVNC 292.5M
  • MPLN 302.9M
  • IPO Year
  • RVNC 2014
  • MPLN N/A
  • Fundamental
  • Price
  • RVNC $3.27
  • MPLN $0.37
  • Analyst Decision
  • RVNC Buy
  • MPLN Hold
  • Analyst Count
  • RVNC 9
  • MPLN 1
  • Target Price
  • RVNC $12.00
  • MPLN $2.00
  • AVG Volume (30 Days)
  • RVNC 1.7M
  • MPLN 5.9M
  • Earning Date
  • RVNC 08-06-2024
  • MPLN 08-01-2024
  • Dividend Yield
  • RVNC N/A
  • MPLN N/A
  • EPS Growth
  • RVNC N/A
  • MPLN N/A
  • EPS
  • RVNC N/A
  • MPLN N/A
  • Revenue
  • RVNC $236,645,000.00
  • MPLN $959,438,000.00
  • Revenue This Year
  • RVNC $20.63
  • MPLN $7.02
  • Revenue Next Year
  • RVNC $34.80
  • MPLN $6.32
  • P/E Ratio
  • RVNC N/A
  • MPLN N/A
  • Revenue Growth
  • RVNC 54.59
  • MPLN N/A
  • 52 Week Low
  • RVNC $2.30
  • MPLN $0.26
  • 52 Week High
  • RVNC $24.87
  • MPLN $2.16
  • Technical
  • Relative Strength Index (RSI)
  • RVNC 63.29
  • MPLN 46.34
  • Support Level
  • RVNC $2.40
  • MPLN $0.26
  • Resistance Level
  • RVNC $2.75
  • MPLN $0.33
  • Average True Range (ATR)
  • RVNC 0.23
  • MPLN 0.05
  • MACD
  • RVNC 0.09
  • MPLN 0.01
  • Stochastic Oscillator
  • RVNC 95.10
  • MPLN 51.80

About RVNC Revance Therapeutics Inc.

Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.

About MPLN MultiPlan Corporation

MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

Share on Social Networks: